The future is around the corner: Noninvasive diagnosis of progressive nonalcoholic steatohepatitis

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Hepatology

• Publication date

  2008-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/hep.22140PMID 18220279
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diagnosis of hepatic steatosis and fibrosis by transient elastography in asymptomatic healthy individuals: a prospective study of living related potential liver donors

  2007cited by this paper
• Role of radiologic modalities in the management of non-alcoholic steatohepatitis.

  2007cited by this paper
• Diagnostic value of serum protein profiling by SELDI‐TOF ProteinChip compared with a biochemical marker, FibroTest, for the diagnosis of advanced fibrosis in patients with chronic hepatitis C

  2007cited by this paper
• The role of genomics and proteomics: technologies in studying non-alcoholic fatty liver disease.

  2007cited by this paper
• The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD

  2007cited by this paper
• Nonalcoholic Fatty Liver Disease in Severely Obese Subjects

  2007cited by this paper
• Percutaneous liver biopsy in clinical practice

  2007cited by this paper
• Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers

  2007cited by this paper
• Hyaluronic acid levels can predict severe fibrosis and platelet counts can predict cirrhosis in patients with nonalcoholic fatty liver disease

  2006cited by this paper
• A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C.

  2006cited by this paper
• Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease

  2006cited by this paper
• Noninvasive diagnosis of liver fibrosis by ultrasonic transient elastography (Fibroscan)

  2006cited by this paper
• A novel panel of blood markers to assess the degree of liver fibrosis

  2005cited by this paper
• Design and validation of a histological scoring system for nonalcoholic fatty liver disease

  2005cited by this paper
• Sampling variability of liver biopsy in nonalcoholic fatty liver disease.

  2005cited by this paper
• Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis

  2005cited by this paper
• Serum markers detect the presence of liver fibrosis: a cohort study.

  2004cited by this paper
• A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C

  2003cited by this paper
• Transient elastography: a new noninvasive method for assessment of hepatic fibrosis.

  2003cited by this paper
• The utility of radiological imaging in nonalcoholic fatty liver disease.

  2002cited by this paper
• Practices of Liver Biopsy in France: Results of a Prospective Nationwide Survey

  2000cited by this paper
• Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.

  1999cited by this paper
• Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

  1999cited by this paper
• Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations.

  1998cited by this paper

• Association of lipids in lipoprotein subfractions with liver fibrosis in a mouse model of metabolic dysfunction-associated steatohepatitis.

  2025cites this paper
• Plasma Amino Acids in NAFLD Patients with Obesity Are Associated with Steatosis and Fibrosis: Results from the MAST4HEALTH Study

  2023cites this paper
• Predictors of Nonalcoholic Steatohepatitis Severity in Obese Patients Undergoing Bariatric Surgery: A Cross-Sectional Study

  2023cites this paper
• Role of serum hyaluronic acid in predicting necroinflammatory activity of the nonalcoholic fatty liver disease

  2022cites this paper
• Non-alcoholic fatty liver disease (NAFLD) and mental illness: Mechanisms linking mood, metabolism and medicines

  2022cites this paper
• The Association Between Coffee Consumption and Nonalcoholic Fatty Liver Disease in the South Korean general population.

  2021cites this paper
• Clinical Significance of HSPD1/MMP14/ITGB1/miR-6881-5P/Lnc-SPARCL1-1:2 RNA Panel in NAFLD/NASH Diagnosis: Egyptian Pilot Study

  2021cites this paper
• Noninvasive Diagnosis of NAFLD and NASH

  2020cites this paper
• Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

  2020cites this paper
• Characterizing Fatty Liver in vivo in Rabbits, Using Quantitative Ultrasound.

  2019cites this paper
• Cell-Free Circulating Nucleic Acids as Early Biomarkers for NAFLD and NAFLD-Associated Disorders

  2018cites this paper
• Clinical Criteria Correlated with the Incidence of Patients with Non‐alcoholic Fatty Liver Disease

  2017cites this paper
• Nonalcoholic fatty liver disease: Diagnostic biomarkers

  2017cites this paper
• Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis

  2017cites this paper
• Non-alcoholic fatty liver disease and cardiovascular risk

  2017cites this paper
• Oral choline tolerance test as a novel noninvasive method for predicting nonalcoholic steatohepatitis

  2014cites this paper
• In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not.

  2013cites this paper
• Knowledge-Based Identification of Soluble Biomarkers: Hepatic Fibrosis in NAFLD as an Example

  2013cites this paper
• Resistin expression correlates with steatohepatitis in morbidly obese patients

  2013cites this paper
• Liver Disease-Related Proteomics

  2013cites this paper
• Circulating resistin is elevated in patients with non-alcoholic fatty liver disease and is associated with steatosis, portal inflammation, insulin resistance and nonalcoholic steatohepatitis scores.

  2012cites this paper
• Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

  2012cites this paper
• Nonalcoholic Fatty Liver Disease in Lean Individuals in the United States

  2012cites this paper
• Serum biomarkers in nonalcoholic steatohepatitis: value for assessing drug effects?

  2012cites this paper
• Systematic Analysis of the Gene Expression in the Livers of Nonalcoholic Steatohepatitis: Implications on Potential Biomarkers and Molecular Pathological Mechanism

  2012cites this paper
• Plasma fibrinogen-like protein 2 levels in patients with non-alcoholic fatty liver disease.

  2011cites this paper
• A Biomarker Panel for Non-alcoholic Steatohepatitis (NASH) and NASH-Related Fibrosis

  2011cites this paper
• Stéatose hépatique non alcoolique et stéatohépatite non alcoolique

  2011cites this paper
• Clinical predictors of fibrosis in patients with chronic liver disease

  2010cites this paper
• Nonalcoholic fatty liver disease: detection of elevated nicotinamide adenine dinucleotide phosphate with in vivo 3.0-T 31P MR spectroscopy with proton decoupling.

  2010cites this paper
• Phosphoproteomic biomarkers predicting histologic nonalcoholic steatohepatitis and fibrosis.

  2010cites this paper
• The value of serum adipokine measurement in non‐alcoholic fatty liver disease

  2009cites this paper
• Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease.

  2009cites this paper
• Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: histological diagnostic criteria and scoring systems

  2009cites this paper
• Nonalcoholic fatty liver disease: a practical approach to evaluation and management.

  2009cites this paper
• Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease.

  2009cites this paper
• Non alcoholic fatty liver disease and metabolic syndrome.

  2009cites this paper
• CLINICAL—LIVER, PANCREAS, AND BILIARY TRACT Performance of ELF Serum Markers in Predicting Fibrosis Stage in Pediatric Non-Alcoholic Fatty Liver Disease

  2009cites this paper
• Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management

  2009cites this paper
• Imaging of nonalcoholic steatohepatitis: advantages and pitfalls of ultrasonography and computed tomography.

  2009cites this paper
• Reply to the Letter to the Editor: “A “Biomarker Biopsy” for the Diagnosis of NASH: Promises from CK-18 Fragments” by Yusuf Yilmaz, Engin Ulukaya, Enver Dolar

  2008cites this paper
• Alcoholic Liver Disease: Clinical and Sonographic Features

  2008cites this paper
• Liver biopsy versus noninvasive testing in chronic hepatitis C: Where do we stand in 2008?

  2008cites this paper
• Non-Alcoholic Fatty Liver Disease : A clinical and histopathological study

  2008cites this paper
• Review article: current management of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis

  2008cites this paper
• World Journal of Hepatology

  year unknowncites this paper